Cardiorenal benefits of finerenone: protecting kidney and heart

Persons with diabetes and chronic kidney disease (CKD) have a high residual risk of developing cardiovascular (CV) complications despite treatment with renin-angiotensin system blockers and sodium-glucose cotransporter type 2 inhibitors. Overactivation of mineralocorticoid receptors plays a key role...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Juanatey, José R., Górriz, Jose Luis, Ortiz, Alberto, Valle, Alfonso, Soler, Maria Jose, Facila, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891162/
https://www.ncbi.nlm.nih.gov/pubmed/36719097
http://dx.doi.org/10.1080/07853890.2023.2171110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891162/
https://www.ncbi.nlm.nih.gov/pubmed/36719097
http://dx.doi.org/10.1080/07853890.2023.2171110

Ejemplares similares